At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MSB Mesabi
Trading 12-11 14:14:17 EST
35.00
+0.31
+0.90%
High35.49Low34.08Vol14.46K
Open34.39D1 Closing34.69Amplitude4.06%
Mkt Cap459.21MTradable Cap458.86MTotal Shares13.12M
T/O505.29KT/O Rate0.11%Tradable Shares13.11M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Mesoblast (ASX:MSB) Valuation Check as Investors Eye Piper Sandler Healthcare Conference Update
Simply Wall St.  ·  12-10 21:27
Mesoblast (ASX:MSB) Valuation Check as Investors Eye Piper Sandler Healthcare Conference Update
Matrixport Appoints Dominik Oggenfuss as Chief Executive Officer of Matrixport Asset Management AG
prnewswire  ·  12-10 16:00
Matrixport Appoints Dominik Oggenfuss as Chief Executive Officer of Matrixport Asset Management AG
Mesoblast Participation at Piper Sandler Conference
GlobeNewswire  ·  12-04
Mesoblast Participation at Piper Sandler Conference
Mesoblast (ASX:MSB) Is Up 17.3% After Lifting Revenue Guidance and Announcing NIH Trial Collaboration Has The Bull Case Changed?
Simply Wall St.  ·  11-29
Mesoblast (ASX:MSB) Is Up 17.3% After Lifting Revenue Guidance and Announcing NIH Trial Collaboration Has The Bull Case Changed?
A Look at Mesoblast (ASX:MSB) Valuation as New Ryoncil Sales Forecast and Pivotal Trial Spark Attention
Simply Wall St.  ·  11-27
A Look at Mesoblast (ASX:MSB) Valuation as New Ryoncil Sales Forecast and Pivotal Trial Spark Attention
How a Seasoned CFO Appointment Could Shape Mesoblast's (ASX:MSB) Commercial Transformation
Simply Wall St.  ·  11-21
How a Seasoned CFO Appointment Could Shape Mesoblast's (ASX:MSB) Commercial Transformation
Mesoblast and BMT CTN to Initiate Pivotal Trial of Ryoncil® as Part of First-Line Regimen in Adults with Severe Acute GVHD Refractory to Steroids
GlobeNewswire  ·  11-21
Mesoblast and BMT CTN to Initiate Pivotal Trial of Ryoncil® as Part of First-Line Regimen in Adults with Severe Acute GVHD Refractory to Steroids
iFAST vs SGX: Which Growth Stock Could Deliver Better Returns in 2026?
The Smart Investor  ·  11-17
iFAST vs SGX: Which Growth Stock Could Deliver Better Returns in 2026?
Press Release: James M. O'Brien Appointed Chief Financial Officer at Mesoblast
Dow Jones  ·  11-17
Press Release: James M. O'Brien Appointed Chief Financial Officer at Mesoblast
Mesoblast (ASX:MSB) Valuation Spotlight as FDA Reviews Opioid-Reducing Therapy Data
Simply Wall St.  ·  11-17
Mesoblast (ASX:MSB) Valuation Spotlight as FDA Reviews Opioid-Reducing Therapy Data
FDA Review of Opioid-Reduction Data Could Be a Game Changer for Mesoblast (ASX:MSB)
Simply Wall St.  ·  11-12
FDA Review of Opioid-Reduction Data Could Be a Game Changer for Mesoblast (ASX:MSB)
Mesoblast to Meet With FDA Next Month to Discuss Rexlemestrocel-L and Opioid Cessation
GlobeNewswire  ·  11-05
Mesoblast to Meet With FDA Next Month to Discuss Rexlemestrocel-L and Opioid Cessation
Nyse Order Imbalance 11228.0 Shares on Buy Side
THOMSON REUTERS  ·  10-24
Nyse Order Imbalance 11228.0 Shares on Buy Side
Mr. Beast's Financial Gamble
Blockbeats  ·  10-23
Mr. Beast's Financial Gamble
Mesoblast (ASX:MSB) Valuation in Focus After Rising Ryoncil® Revenues and New US Reimbursement Pathways
Simply Wall St.  ·  10-21
Mesoblast (ASX:MSB) Valuation in Focus After Rising Ryoncil® Revenues and New US Reimbursement Pathways
Mesabi Trust Up Nearly 14%, on Track for Highest Close Since October 2021 -- Data Talk
Dow Jones  ·  10-20
Mesabi Trust Up Nearly 14%, on Track for Highest Close Since October 2021 -- Data Talk
Mesoblast (ASX:MSB) J-Code for Ryoncil Secures Reimbursement Access Is the Commercial Strategy Evolving?
Simply Wall St.  ·  10-15
Mesoblast (ASX:MSB) J-Code for Ryoncil Secures Reimbursement Access Is the Commercial Strategy Evolving?
Mesoblast (ASX:MSB) Valuation in Focus After Ryoncil Secures U.S. Reimbursement Milestone
Simply Wall St.  ·  10-12
Mesoblast (ASX:MSB) Valuation in Focus After Ryoncil Secures U.S. Reimbursement Milestone
Mesabi Trust - Declares $0.34 per Unit Distribution Payable Nov 20, 2025
THOMSON REUTERS  ·  10-11
Mesabi Trust - Declares $0.34 per Unit Distribution Payable Nov 20, 2025
Press Release: Mesabi Trust Press Release
Dow Jones  ·  10-11
Press Release: Mesabi Trust Press Release

Introduction

Company Name.
Mesabi
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Mesabi Trust, a royalty trust, engages in iron ore mining business in the United States. Mesabi Trust was founded in 1961 and is based in New York, New York.
Issue price:
--